TRIBTRINITY BIOTECH PLC

Nasdaq trinitybiotech.com


$ 2.38 $ -0.01 (-0.29 %)    

Tuesday, 20-Aug-2024 14:49:42 EDT
QQQ $ 480.18 $ -1.12 (-0.23 %)
DIA $ 408.54 $ -0.35 (-0.09 %)
SPY $ 558.65 $ -0.51 (-0.09 %)
TLT $ 98.68 $ 0.38 (0.39 %)
GLD $ 232.46 $ -1.26 (-0.54 %)
$ 2.387
$ 2.33
$ 2.33 x 100
-- x --
$ 2.33 - $ 2.38
$ 1.49 - $ 4.59
36,751
na
91.49M
$ 0.41
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 trinity-biotech-obtains-extension-to-demonstrate-compliance-with-nasdaq-listing-requirements

Trinity Biotech plc (NASDAQ:TRIB), a commercial stage biotechnology company focused on human diagnostics and diabetes managemen...

 trinity-biotech-preliminary-q2-2024-revenue-155m-16m-entered-into-medscience-distribution-agreement-in-uk-effective-as-of-august-1-2024-which-encompasses-clinical-chemistry-infectious-disease-and-autoimmune-product

-Second Quarter 2024 revenues are expected to fall between $15.5-$16.0 million, reflecting double digit percentage year over ye...

 department-of-veterans-affairs-awards-4m-contract-to-trinity-biotech-subsidiary-biopool-us-inc-for-analytical-laboratory-instrument-manufacturing-cost-per-test-services-66-iii

https://sam.gov/opp/05464da507eb41a69c3ccf9b5030d592/view

 on-july-12-2024-trinity-biotech-entered-into-an-atm-offering-agreement-with-craig-hallum-capital-group-pursuant-to-which-may-sell-up-to-55m-of-its-adss-each-ads-representing-20-of-the-companys-a-ordinary-shares-co-will-also-pay-craig-hallum-a-commission-equal-to-3-of-the-gross-sales-price-of-adss

On July 12, 2024, Trinity Biotech plc (the "Company") entered into an At the Market Offering Agreement (the "Sales ...

 trinity-biotech-announces-appointment-of-louise-tallon-as-chief-financial-officer-des-fitzgerald-will-continue-as-interim-cfo-until-late-july-2024--reiterates-financial-guidance-and-intend-to-achieve-20m-of-annualized-run-rate-ebitdaso-on-annualized-revenues-of-75m-by-q2-2025

Trinity Biotech plc (NASDAQ:TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management...

 trinity-biotech-receives-increased-orders-for-trinscreen-hiv-total-orders-received-to-date-for-supply-in-2024-to-6m-increased-its-expected-2024-sales-revenue-for-trinscreen-hiv-to-over-8m

Trinity Biotech plc (NASDAQ:TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management...

 trinity-biotech-says-it-is-targeting-approximately-20m-of-annualized-run-rate-ebitda-on-annualized-run-rate-revenues-of-approximately-75m-by-q2-2025

The company said  this outlook is predicated solely on growth from the existing businesses including haemoglobin testing and HI...

 trinity-biotech-q4-eps-072-up-from-133-yoy-sales-1343m-miss-1500m-estimate

Trinity Biotech (NASDAQ:TRIB) reported quarterly losses of $(0.72) per share. This is a 45.86 percent increase over losses of $...

 earnings-scheduled-for-april-4-2024

Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on r...

 trinity-biotech-finalizes-effective-date-as-february-23-2024-for-ads-ratio-change

Trinity Biotech Plc.(NASDAQ:TRIB) (the "Company") today announced that it has finalized the effective date of its ratio...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION